CYTOKINETICS INC financial data

Symbol
CYTK on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 641% % -22.7%
Debt-to-equity -512% % 33.2%
Return On Equity 233% % -30.5%
Return On Assets -56.4% % -12.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122,264,929 shares 3.6%
Common Stock, Shares, Outstanding 118,209,139 shares 16.3%
Entity Public Float $5,600,000,000 USD 180%
Common Stock, Value, Issued $122,000 USD 3.39%
Weighted Average Number of Shares Outstanding, Basic 119,982 shares 1.95%
Weighted Average Number of Shares Outstanding, Diluted 119,982 shares 1.95%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $87,211,000 USD 2609%
Research and Development Expense $405,257,000 USD 22.5%
General and Administrative Expense $254,886,000 USD 29.3%
Operating Income (Loss) $-572,932,000 USD -9.21%
Nonoperating Income (Expense) $51,964,000 USD 17.8%
Net Income (Loss) Attributable to Parent $-751,944,000 USD -30.5%
Earnings Per Share, Basic -6 USD/shares -16.9%
Earnings Per Share, Diluted -6 USD/shares -16.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $225,467,000 USD 381%
Cash, Cash Equivalents, and Short-term Investments $1,300,000,000 USD 0%
Accounts Receivable, after Allowance for Credit Loss, Current $1,808,000 USD 641%
Assets, Current $977,349,000 USD -4.05%
Property, Plant and Equipment, Net $76,001,000 USD 18.3%
Operating Lease, Right-of-Use Asset $77,580,000 USD 1.62%
Other Assets, Noncurrent $16,810,000 USD 118%
Assets $1,436,557,000 USD 0.04%
Accounts Payable, Current $22,084,000 USD 90.7%
Employee-related Liabilities, Current $33,199,000 USD 19.1%
Accrued Liabilities, Current $61,633,000 USD 23.7%
Liabilities, Current $142,144,000 USD 29.4%
Operating Lease, Liability, Noncurrent $110,655,000 USD -3.57%
Other Liabilities, Noncurrent $1,612,000 USD
Liabilities $1,957,680,000 USD 35%
Accumulated Other Comprehensive Income (Loss), Net of Tax $34,000 USD -99.4%
Retained Earnings (Accumulated Deficit) $-3,303,688,000 USD -29.5%
Stockholders' Equity Attributable to Parent $-521,123,000 USD -3646%
Liabilities and Equity $1,436,557,000 USD 0.04%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-131,617,000 USD -1.63%
Net Cash Provided by (Used in) Financing Activities $4,754,000 USD -95.4%
Net Cash Provided by (Used in) Investing Activities $105,956,000 USD 225%
Common Stock, Shares Authorized 163,000,000 shares 0%
Common Stock, Shares, Issued 118,209,139 shares 16.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $-21,177,000 USD -405%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $228,579,000 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $9,647,000 USD -5.48%
Deferred Tax Assets, Valuation Allowance $712,907,000 USD 24.5%
Deferred Tax Assets, Gross $734,951,000 USD 23.2%
Operating Lease, Liability $131,560,000 USD -4.89%
Payments to Acquire Property, Plant, and Equipment $5,664,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $-757,297,000 USD -32.8%
Lessee, Operating Lease, Liability, to be Paid $190,975,000 USD -8.94%
Property, Plant and Equipment, Gross $102,992,000 USD 6.07%
Operating Lease, Liability, Current $20,647,000 USD 9.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $20,179,000 USD 3.15%
Lessee, Operating Lease, Liability, to be Paid, Year One $19,563,000 USD 4.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $59,415,000 USD -16.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three $20,514,000 USD 1.66%
Deferred Tax Assets, Operating Loss Carryforwards $282,974,000 USD 22%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $31,005,000 USD 22.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four $20,738,000 USD 1.09%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $2,300,000 USD -1.33%
Share-based Payment Arrangement, Expense $108,030,000 USD 18.6%
Interest Expense $11,353,000 USD 27.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%